MD Jaiswal Lecture Hoag
Introduction to ECMO for ARDS
Acute Respiratory Distress Syndrome (ARDS)
Clinical definition involves criteria that leads to critical care management strategies.
Ventilator Induced Lung Injury (VILI)
Understanding mechanisms and impacts of mechanical ventilation in ARDS patients.
Strategies to Improve Mortality
ARDS Net guidelines and protocols to manage serious cases.
Use of prone positioning, neuromuscular blocking agents (NMBA).
Salvage Strategies (No proven mortality benefit)
Pressure control strategies, APRV, nitric oxide (iNO), Flolan, and ECMO as salvage options.
Definition and Physiology of ARDS
Clinical Definition (Old Definition)
Key Criteria:
Bilateral infiltrates on chest X-ray (CXR)
PaO2/FiO2 ratio <200
Pulmonary capillary wedge pressure (PCWP) <18
Non-cardiogenic pulmonary edema (Bernard et al., 1994).
Berlin Criteria for ARDS
Classification of ARDS Severity:
Mild ARDS: PaO2/FiO2 ratio <300
Moderate ARDS: PaO2/FiO2 ratio <200
Severe ARDS: PaO2/FiO2 ratio <100
Physiological Changes:
Endothelial injury and protein-rich edema influx.
Impaired removal of edema leading to complications like fibrosing alveolitis.
Mortality and Complications in ARDS
Mortality Rate: 40% to 60%.
Hypoxemia is not the direct cause of death; mortality stems from advanced fibroproliferative phase and mechanical ventilation complications.
Complications include multisystem organ failure, especially due to VILI.
Mechanisms of Ventilator Induced Lung Injury (VILI)
Types of Injuries:
Atelectrauma: Lung collapse due to low lung volume ventilation.
Baro/volutrauma: Injury from hyperinflation and overdistention when using high volume ventilation (Slutsky, NEJM 2013).
Management Strategies in ARDS
ARDS Network (ARDSNet)
Low tidal volume ventilation strategy at 6 ml/kg.
Plateau pressure should be maintained <30 mmHg.
Use of NMBA, prone positioning as effective management methods.
Evidence of Mortality Benefit: Strategies include Low Tidal Volume and prone positioning.
ARDS Network Trials
Notable Trials:
Multi-center studies comparing tidal volumes of 6 ml/kg versus traditional volumes of 12 ml/kg proved that lower tidal volumes effectively reduced morbidity and mortality.
Compliance with protocols critical during the first 24-48 hours for improved outcomes.
Lung Protective Strategies
Implementation of low tidal volume strategy at 6 ml/kg with plateau pressure <30.
PEEP Strategies: Use high/low PEEP to manage oxygenation without significant mortality benefit observed between the two.
Monitoring for complications with higher PEEP, such as hemodynamic compromise.
Prone Positioning in ARDS
Effectiveness: Prone positioning improves survival rates, P/F ratios, and reduces lung overdistension; implementation should occur within 48 hours of ARDS diagnosis.
Duration of prone therapy recommended for a minimum of 48-72 hours.
Neuromuscular Blocking Agents (NMBA) in ARDS
NMBA enhances lung protective ventilation and improves patient outcomes in severe ARDS (PaO2/FiO2 <120).
Associated with increased ventilator-free days and reduced incidence of barotrauma.
ECMO in Severe ARDS
Definition: Extracorporeal Membrane Oxygenation (ECMO) provides mechanical support for cardiac/pulmonary failure; derived from cardiac surgery techniques.
Types of ECMO:
VA ECMO: For cardiogenic shock.
VV ECMO: For severe respiratory failure.
Clinical Indications: Used in severe respiratory failure, ARDS due to various underlying causes.
EOLIA Trial
Overview: The EOLIA trial studies ECMO's effectiveness in severe ARDS; supported findings favoring early initiation of ECMO over conventional care methods.
Conclusions: Early ECMO initiation might not significantly reduce 60-day mortality, but could offer benefits as a rescue therapy.
Future Directions and Considerations
Careful patient selection and timing for ECMO are crucial.
Detailed monitoring of the patient's condition, including compliance with lung protective strategies.
Highlights the importance of evolving standards and guidelines for ARDS management worldwide.